BONO, SILVIA
BONO, SILVIA
Scienze Biomediche, Sperimentali e Cliniche 'Mario Serio'
An antisense oligodeoxyribonucleotide down-regulating uPAR expression inhibits retinal neoangiogenesis both in vitro and in in vivo
2011 Federico Di, Gesualdo; Lulli, Matteo; Bono, Silvia; Lupia, Antonella; Witort, Ewa; Dal Monte, Massimo; Capaccioli, Sergio
ENERGY RESTRICTION REGULATES BCR/ABL EXPRESSION IN CHRONIC MYELOID LEUKAEMIA CELLS VIA TRANSCRIPTIONAL/POST-TRANSCRIPTIONAL CONTROL
2014 Bono S; Lulli M; Di Gesualdo F; Tusa I; Cheloni G; Rovida E; Dello Sbarba P
Energy shortage regulates BCR-Abl expression in Chronic Myeloid Leukemia cells via transcriptional/post-transcriptional control
2014 Silvia Bono
Imatinib-mesylate enhances the maintenance of chronic myeloid leukemia stem cell potential in the absence of glucose.
2018 Bono, Silvia; Dello Sbarba, Persio; Lulli, Matteo
In vitro and in vivo inhibition of proangiogenic retinal phenotype by an antisense oligonucleotide downregulating uPAR expression
2017 Matteo lulli, ; Maurizio cammalleri, ; Irene granucci, ; Ewa witort, ; Silvia, Bono; Federico di, Gesualdo; Antonella lupia, ; Rosa loffredo, ; Giovanni casini, ; Massimo dal, Monte; Sergio capaccioli
Sensitivity to imatinib of KCL22 chronic myeloid leukemia cell survival/growth and stem cell potential under glucose shortage
2018 Bono, Silvia; Dello Sbarba, Persio*; Lulli, Matteo
The Leukemic Stem Cell Niche: Adaptation to “Hypoxia” versus Oncogene Addiction
2017 Cheloni, G; Poteti, M; Bono, S; Masala, E; Mazure, N; Rovida, E; Lulli, M; Dello Sbarba, P
The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy.
2014 Rovida E; Peppicelli S; Bono S; Bianchini F; Tusa I; Cheloni G; Marzi I; Cipolleschi MG; Calorini L; Dello Sbarba P